Bibliographic Details
| Title: |
Molecular and cellular signatures accompanying early disease clearance in Ulcerative Colitis patients treated with vedolizumab in the VERDICT trial. |
| Authors: |
Powell, N.1, Mehandru, S.2, Silverberg, M.3, Peyrin-Biroulet, L.4,5,6, Hernandez-Rocha, C.3, Colombel, J. F.7, D’Haens, G.8, Moran, G.9,10, Sebastian, S.11, Travis, S.12, Filice, M.13, Massimino, L.13, Picard, J.13, Sangiorgi, B.13, Shackelton, L.13, Smith, M.13, Teft, W.13, Arunachalam, V.14, Agboton, C.14, Farahmand, S.14 |
| Source: |
Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi206-i209. 4p. |
| Database: |
Academic Search Ultimate |
